Narayana Hrudayalaya quarterly results

Q2 FY27 · Jul–Sep 2026

₹ crore	Q2 FY27	Q2 FY26	Change
Revenue	2,844	1,644	+73.0%
EBITDA	554	403	+37.6%
EBITDA margin	19.5%	24.5%	−5.0 pts
Profit before tax	343	297	+15.7%
Net profit	301	258	+16.5%
EPS	₹14.82	₹12.72	+16.5%

Every quarter

₹ crore except per share

Tap a line for its trend	Q2 FY27Sep 2026	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Earlier quartersAlpha Plus

Expenses
	2,844	2,684	2,594	2,151	1,644	1,507	1,475	1,367	1,400	1,341	1,279	1,204	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	51.5	35.5	29.2	23.2	24.0	23.8	26.8	18.4	23.6	23.5	23.9	17.9
	2,896	2,719	2,623	2,174	1,668	1,531	1,502	1,385	1,424	1,364	1,303	1,222
	554	520	525	407	323	305	305	270	317	282	294	259
	−6.5	−6.0	−18.0	−26.0	−0.7	0.4	−0.1	6.6	−16.4	6.3	−20.4	−14.9
	736	725	749	459	299	296	275	277	282	276	249	254
	96.7	86.8	91.3	65.0	42.3	45.2	40.7	36.6	35.1	34.0	28.0	25.1
	163	156	154	122	87.5	84.3	82.5	70.0	65.1	61.7	64.8	63.2
	1,007	975	828	943	620	569	537	506	509	473	462	426
	2,550	2,457	2,329	1,971	1,371	1,300	1,241	1,166	1,192	1,133	1,078	1,013
	554	470	510	367	403	337	358	307	308	304	295	279
	391	314	356	245	315	253	275	237	243	242	230	216
Profit
	346	262	294	203	297	231	261	219	232	232	226	209
	−2.4	0.0	−0.0	−50.9	0.0	0.0	−8.4	0.0	0.0	0.0	0.0	0.0
	343	262	294	152	297	231	253	219	232	232	226	209
	49.3	55.7	76.1	30.1	36.2	34.2	42.0	28.8	29.1	29.9	51.2	26.1
	−7.1	−2.6	−12.0	−7.8	1.0	0.6	14.8	−3.1	3.9	0.3	−16.4	−5.7
	42.2	53.1	64.1	22.3	37.2	34.8	56.8	25.8	33.0	30.2	34.8	20.5
	0.0	−1.9	−2.0	−1.9	−1.3	−0.4	0.0	0.0	0.0	0.0	0.0	0.0
	301	207	224	127	258	197	197	193	199	201	191	188
	301	207	228	128	258	196	196	193	199	201	191	188
	0.0	0.0	−4.0	−1.3	0.2	0.7	1.0	0.0	0.0	0.0	0.0	0.0
	62.1	−13.2	96.5	30.3	69.4	0.5	−5.9	36.4	5.3	−2.1	4.4	−1.1
	363	194	320	157	328	197	191	229	204	199	195	187
	301	207	224	127	258	197	197	193	199	201	191	188
	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1
Per share
	₹14.82	₹10.20	₹11.02	₹6.24	₹12.72	₹9.68	₹9.71	₹9.50	₹9.78	₹9.92	₹9.39	₹9.26
	₹14.82	₹10.20	₹11.02	₹6.24	₹12.72	₹9.68	₹9.71	₹9.50	₹9.78	₹9.92	₹9.39	₹9.26
Continuing & discontinued operations
	0.0	0.0	−3.3	−1.3	0.2	0.7	1.8	0.0	0.0	0.0	0.0	0.0
	0.0	0.0	0.7	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0
Other comprehensive income — detail
	62.1	−13.2	96.5	30.3	69.4	0.5	−5.9	—	—	—	—	—
	1.0	−6.5	0.8	−1.3	−1.9	0.9	−0.0	−0.5	−0.7	−4.1	−0.5	−0.8
	0.4	−1.2	0.6	−0.2	0.1	−0.2	−0.4	—	—	—	—	—
	—	—	—	—	—	—	—	−0.1	−0.2	−0.9	−0.2	−0.2
	61.5	−7.9	96.4	31.3	71.4	−0.6	−6.3	36.8	5.8	1.1	4.7	−0.5
	0.0	0.0	0.0	−0.1	0.0	0.0	0.0	—	—	—	—	—
	—	—	—	—	—	—	—	0.0	−0.0	−0.0	−0.0	0.0
	363	194	320	157	328	197	191	229	204	199	195	187
	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1
Per share — as-filed variants
	₹14.82	₹10.20	₹11.22	₹6.30	₹12.71	₹9.65	₹9.66	₹9.50	₹9.78	₹9.92	₹9.39	₹9.26
	₹14.82	₹10.20	₹11.22	₹6.30	₹12.71	₹9.65	₹9.66	₹9.50	₹9.78	₹9.92	₹9.39	₹9.26
	₹0.00	₹0.00	−₹0.20	−₹0.06	₹0.01	₹0.03	₹0.05	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00
	₹0.00	₹0.00	−₹0.20	−₹0.06	₹0.01	₹0.03	₹0.05	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	2,296	2,169	2,087	1,770	1,322	1,201	1,170	1,090	1,100	1,053	1,006	959
	80.7%	80.8%	80.5%	82.3%	80.4%	79.7%	79.3%	79.8%	78.6%	78.5%	78.6%	79.7%
Adjusted (ex-exceptional items) — derived
	346	262	294	203	297	231	261	219	232	232	226	209
	−2.4	0.0	−0.0	−50.9	0.0	0.0	−8.4	0.0	0.0	0.0	0.0	0.0
	303	207	224	170	258	197	204	193	199	201	191	188
	₹14.92	₹10.20	₹11.02	₹8.38	₹12.72	₹9.68	₹10.03	₹9.50	₹9.78	₹9.92	₹9.39	₹9.26

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NH₹1,714.50

Narayana Hrudayalaya Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersAPOLLOHOSP MAXHEALTH FORTIS NEULANDLAB NATCOPHARM LALPATHLAB SAILIFE COHANCEMcap ₹35,038 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Revenue from Operations	1,203.6	1,279.4	1,341.0	1,400.0	1,366.7	1,475.4	1,507.3	1,643.8	2,151.2	2,593.8	2,683.6	2,844.0
Other Income	17.9	23.9	23.5	23.6	18.4	26.8	23.8	24.0	23.2	29.2	35.5	51.5
Total Income	1,221.5	1,303.3	1,364.4	1,423.6	1,385.0	1,502.3	1,531.1	1,667.8	2,174.4	2,623.0	2,719.1	2,895.5
Expenses
+ Purchases of Stock-in-Trade	259.2	293.9	281.9	316.6	269.7	305.4	305.4	323.0	407.4	524.6	520.3	554.2
+ Changes in Inventories	-14.9	-20.4	6.3	-16.4	6.6	-0.1	0.4	-0.7	-26.0	-18.0	-6.0	-6.5
+ Employee Benefit Expense	254.2	249.4	276.4	282.1	277.3	275.4	295.5	299.1	459.5	748.9	724.8	735.9
+ Finance Costs	25.1	28.0	34.0	35.1	36.6	40.7	45.2	42.3	65.0	91.3	86.8	96.7
+ Depreciation & Amortisation	63.2	64.8	61.7	65.1	70.0	82.5	84.3	87.5	122.3	153.8	156.1	162.9
+ Other Expenses	426.2	462.0	472.5	509.3	506.1	537.0	569.0	620.0	943.0	828.3	974.8	1,006.6
Total Expenses	1,012.9	1,077.7	1,132.8	1,191.8	1,166.2	1,240.9	1,299.8	1,371.0	1,971.2	2,328.9	2,456.8	2,549.8
EBITDA	278.9	294.6	303.9	308.4	307.0	357.7	337.0	402.5	367.2	510.0	469.7	553.9
EBIT	215.8	229.8	242.2	243.3	237.0	275.2	252.6	315.0	245.0	356.2	313.6	390.9
Profit
PBT before Exceptional Items	208.6	225.6	231.7	231.8	218.8	261.4	231.3	296.8	203.2	294.2	262.3	345.7
+ Exceptional Items	0.0	0.0	0.0	0.0	0.0	-8.4	0.0	0.0	-50.9	-0.0	0.0	-2.4
Pretax Income	208.6	225.6	231.7	231.8	218.8	253.0	231.3	296.8	152.2	294.1	262.3	343.3
+ Current Tax	26.1	51.2	29.9	29.1	28.8	42.0	34.2	36.2	30.1	76.1	55.7	49.3
+ Deferred Tax	-5.7	-16.4	0.3	3.9	-3.1	14.8	0.6	1.0	-7.8	-12.0	-2.6	-7.1
Tax Expense	20.5	34.8	30.2	33.0	25.8	56.8	34.8	37.2	22.3	64.1	53.1	42.2
+ Net Movement in Regulatory Deferral Balances	0.0	0.0	0.0	0.0	0.0	0.0	-0.4	-1.3	-1.9	-2.0	-1.9	0.0
Net Income	188.1	190.8	201.5	198.8	193.1	197.3	196.7	258.5	126.8	224.0	207.3	301.2
+ Net Income — Continuing Ops	188.1	190.8	201.5	198.8	193.1	196.2	196.1	258.3	128.1	228.0	207.3	301.2
+ Net Income — Discontinued Ops	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.2	-1.3	-4.0	0.0	0.0
+ Other Comprehensive Income	-1.1	4.4	-2.1	5.3	36.4	-5.9	0.5	69.4	30.3	96.5	-13.2	62.1
Total Comprehensive Income	187.0	195.2	199.4	204.1	229.4	191.4	197.2	327.9	157.1	320.5	194.0	363.2
Net Income to Common	188.0	190.7	201.4	198.6	192.9	197.2	196.7	258.4	126.7	223.9	207.2	301.0
Minority Interest	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Per Share
Basic EPS	9.26	9.39	9.92	9.78	9.50	9.71	9.68	12.72	6.24	11.02	10.20	14.82
Diluted EPS	9.26	9.39	9.92	9.78	9.50	9.71	9.68	12.72	6.24	11.02	10.20	14.82
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax	0.0	0.0	0.0	0.0	0.0	1.8	0.7	0.2	-1.3	-3.3	0.0	0.0
+ Tax — Discontinued Operations	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.7	0.0	0.0
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	-5.9	0.5	69.4	30.3	96.5	-13.2	62.1
+ Items NOT to be Reclassified to P&L	-0.8	-0.5	-4.1	-0.7	-0.5	-0.0	0.9	-1.9	-1.3	0.8	-6.5	1.0
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	-0.4	-0.2	0.1	-0.2	0.6	-1.2	0.4
+ Tax on Items NOT to be Reclassified — alt tag	-0.2	-0.2	-0.9	-0.2	-0.1	—	—	—	—	—	—	—
+ Items to be Reclassified to P&L	-0.5	4.7	1.1	5.8	36.8	-6.3	-0.6	71.4	31.3	96.4	-7.9	61.5
+ Tax on Items to be Reclassified	—	—	—	—	—	0.0	0.0	0.0	-0.1	0.0	0.0	0.0
+ Tax on Items to be Reclassified — alt tag	0.0	-0.0	-0.0	-0.0	0.0	—	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	186.9	195.1	199.3	204.0	229.3	191.4	197.1	327.8	157.0	320.5	194.0	363.1
Comprehensive Income — Non-controlling Interests	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Per Share — as-filed variants
Basic EPS — Continuing Operations	9.26	9.39	9.92	9.78	9.50	9.66	9.65	12.71	6.30	11.22	10.20	14.82
Diluted EPS — Continuing Operations	9.26	9.39	9.92	9.78	9.50	9.66	9.65	12.71	6.30	11.22	10.20	14.82
Basic EPS — Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.05	0.03	0.01	-0.06	-0.20	0.00	0.00
Diluted EPS — Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.05	0.03	0.01	-0.06	-0.20	0.00	0.00
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	959.4	1,005.9	1,052.7	1,099.8	1,090.3	1,170.1	1,201.5	1,321.6	1,769.7	2,087.2	2,169.4	2,296.3
Gross Margin %	79.71	78.62	78.51	78.56	79.78	79.31	79.71	80.40	82.27	80.47	80.84	80.74
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	208.6	225.6	231.7	231.8	218.8	261.4	231.3	296.8	203.2	294.2	262.3	345.7
− Exceptional Items (reconciliation)	0.0	0.0	0.0	0.0	0.0	-8.4	0.0	0.0	-50.9	-0.0	0.0	-2.4
Net Income Adj (tax-effected)	188.1	190.8	201.5	198.8	193.1	203.8	196.7	258.5	170.3	224.0	207.3	303.3
EPS Adj	9.26	9.39	9.92	9.78	9.50	10.03	9.68	12.72	8.38	11.02	10.20	14.92
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00
Filed Debt Equity	—	1.00	1.00	1.00	1.00	0.67	0.58	0.58	1.30	1.29	1.24	1.21
Filed Dscr	—	3.00	3.00	3.00	3.00	2.57	2.41	3.16	1.93	2.06	2.23	2.58
Filed Iscr	—	9.00	8.00	8.00	7.00	7.22	6.11	7.99	3.31	4.20	4.00	4.55
Paid Up Equity Capital	204.4	204.4	204.4	204.4	204.4	204.4	204.4	204.4	204.4	204.4	204.4	204.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q2 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Narayana Hrudayalaya Q2 FY27 results (July–September 2026)

Narayana Hrudayalaya (NSE: NH) reported its Q2 FY27 results (July–September 2026). Consolidated net profit was ₹301 crore, up 16.5% from ₹258 crore in Q2 FY26 and up 45.3% from ₹207 crore in Q1 FY27. Revenue from operations was ₹2,844 crore, up 73.0% year on year and up 6.0% from the previous quarter.

Q2 FY26 results (a year earlier): 14 November 2025
Q3 FY27 results due by: 14 February 2027

Q2 FY27 at a glance · consolidated

Net profit: ₹301 Cr+16.5% vs Q2 FY26+45.3% vs Q1 FY27
Revenue from operations: ₹2,844 Cr+73.0% vs Q2 FY26+6.0% vs Q1 FY27
Operating margin (EBIT): 13.7%−5.4 pts vs Q2 FY26+2.1 pts vs Q1 FY27EBIT ₹391 Cr
EBITDA: ₹554 Cr+37.6% vs Q2 FY26+17.9% vs Q1 FY27margin 19.5%
Earnings per share (basic): ₹14.82+16.5% vs Q2 FY26+45.3% vs Q1 FY27
Net profit margin: 10.6%−5.1 pts vs Q2 FY26+2.9 pts vs Q1 FY27

Questions

What was Narayana Hrudayalaya's net profit in Q2 FY27?

Consolidated net profit was ₹301 crore, up 16.5% from ₹258 crore in Q2 FY26 and up 45.3% from ₹207 crore in Q1 FY27.

What was Narayana Hrudayalaya's revenue in Q2 FY27?

Revenue from operations was ₹2,844 crore, up 73.0% year on year and up 6.0% from the previous quarter.

What was Narayana Hrudayalaya's operating margin in Q2 FY27?

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹391 crore, a margin of 13.7%, against 11.7% in Q1 FY27 and 19.2% in Q2 FY26. EBITDA was ₹554 crore, 19.5% of revenue.

How were Narayana Hrudayalaya's Q2 FY27 results?

Both grew from a year earlier: net profit was up 16.5% at ₹301 crore and revenue was up 73.0% at ₹2,844 crore. The operating margin was 13.7%, down 5.4 percentage points from 19.2% a year earlier. Against Q1 FY27, net profit was up 45.3% and revenue up 6.0%.

What was Narayana Hrudayalaya's net profit in the first half of FY27?

Consolidated net profit for the first half of FY27 (April–September 2026) was ₹508 crore, up 11.7% from ₹455 crore in the same months a year earlier. Revenue from operations was ₹5,528 crore, up 75.4%.

What is Narayana Hrudayalaya's net profit margin?

Narayana Hrudayalaya's net profit margin was 10.6% in Q2 FY27 (net profit as a share of revenue from operations), against 15.7% in Q2 FY26 (down 5.1 percentage points). For FY26 as a whole it was 10.2%.

What was Narayana Hrudayalaya's EPS in Q2 FY27?

Basic earnings per share were ₹14.82, against ₹12.72 in Q2 FY26.

What was Narayana Hrudayalaya's net profit in FY26?

Consolidated net profit was ₹806 crore in FY26 (April 2025–March 2026), up 2.0% from ₹790 crore in FY25. It was ₹789 crore in FY24 and ₹606 crore in FY23: up 32.9% over three years, 9.9% a year on average.

What was Narayana Hrudayalaya's revenue in FY26?

Revenue from operations was ₹7,896 crore in FY26 (April 2025–March 2026), up 44.0% from ₹5,483 crore in FY25. It was ₹5,018 crore in FY24 and ₹4,525 crore in FY23: up 74.5% over three years, 20.4% a year on average.

How has Narayana Hrudayalaya's profit changed over the last four quarters?

Net profit by quarter: ₹127 crore in Q3 FY26, ₹224 crore in Q4 FY26, ₹207 crore in Q1 FY27 and ₹301 crore in Q2 FY27. That is ₹859 crore over the four quarters, up 1.6% from ₹845 crore in the four quarters before. Revenue from operations: ₹2,151 crore, ₹2,594 crore, ₹2,684 crore and ₹2,844 crore.

When will Narayana Hrudayalaya announce its Q3 FY27 results?

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

Where do these Narayana Hrudayalaya figures come from?

From Narayana Hrudayalaya's own consolidated results filings to NSE, in ₹ crore as filed. Growth compares the same consolidated figures a year and a quarter earlier.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.